ONVO (Organovo Holdings) Earnings per share for the last four quarters

Organovo Holdings Inc (ONVO) - corporate logo

A base of high-tech laboratories in California created the foundation for the development of Organovo Holdings, Inc. (ONVO). Comparable annual EPS TTM growth on the general GURU.Markets platform chart, where this metric equals -61.40, confirms its status as a pioneer in 3D organ bioprinting. This has enabled Organovo Holdings, Inc. (ONVO) to implement robotic molecule screening and automate data processing for liver fibrosis treatment to accelerate drug development.

ONVO organovo.com Net earnings per share (EPS TTM) (02/11/2024 - 02/20/2024)

ONVO (Organovo Holdings, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
- business market valuation indicators:
Fundamental company valuation:ONVO (Organovo Holdings)
Core merchandise of Organovo Corp

Organovo Holdings, Inc. (ONVO) operates in the biopharmaceutical sector, where demand remains stable, but regulatory risks and supply chain disruptions constrain growth. This indicator measures the percentage change in net earnings per share over a rolling year, reflecting capitalization efficiency. In an environment of high borrowing costs, this metric reveals the business's resilience to liquidity contraction. Investors seek a balance here between debt load and potential undervaluation. Analyze this annual EPS TTM chart to assess the company's financial viability.

Competitor analysis

Net earnings per one share for the last twelve months Ascendis Pharma Inc.|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Therapeutics|Net earnings per share (EPS TTM) MTSR|Earnings per share for the last twelve months MLTX (MoonLake Immunotherapeutics AG)|Earnings per share for the last twelve months crinetics.com CRNX|NewAmsterdam Pharma Corp (NAMS) - Net earnings per one share for the last twelve months|SLNO - Earnings per share for the last twelve months|FOLD: Earnings per share for the last twelve months|ETNB: Net earnings per share (EPS TTM)|AGIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Structure Corp|MiMedx Corp (MDXG) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months rezolutebio.com (RZLT)|Net earnings per share for the last 12 months lexpharma.com LXRX|Net earnings per share (EPS TTM) MBX (MBX Biosciences)|Altimmune Corp - Earnings per share for the last twelve months|Aardvark Therapeutics Inc. - Net earnings per share (EPS TTM)|SGMT - Net earnings per share (EPS TTM)|BioAge Labs (BIOA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months biomeafusion.com (BMEA)|Earnings per share for the last twelve months Quince Therapeutics, Inc.|Net earnings per share for the last 12 months Fractyl (GUTS)|Net earnings per share for the last 12 months VTVT (vTv Therapeutics Inc.)|ATPC - Net earnings per one share for the last twelve months|Pluri Inc. - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Synlogic Corp|LPCN - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Matinas BioPharma Holdings, Inc. MTNB|SPRB: Net earnings per share (EPS TTM)|Galecto Corp - Earnings per share for the trailing year|CTCX (carmellrx.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) lumos-pharma.com|Net earnings per share (EPS TTM) RDUS